Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Search

Page Path
HOME > Search
2 "Blood platelets"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Articles
Systemic Inflammatory Response Markers and CA-125 Levels in Ovarian Clear Cell Carcinoma: A Two Center Cohort Study
Hee Seung Kim, Hwa-Young Choi, Maria Lee, Dong Hoon Suh, Kidong Kim, Jae Hong No, Hyun Hoon Chung, Yong Beom Kim, Yong Sang Song
Cancer Res Treat. 2016;48(1):250-258.   Published online March 6, 2015
DOI: https://doi.org/10.4143/crt.2014.324
AbstractAbstract PDFPubReaderePub
Purpose
We compared the predictive and prognostic values of leukocyte differential counts, systemic inflammatory (SIR) markers and cancer antigen 125 (CA-125) levels, and identified the most useful marker in patients with ovarian clear cell carcinoma (OCCC).
Materials and Methods
The study included 109 patients with OCCC who did not have any inflammatory conditions except endometriosis, and underwent primary debulking surgery between 1997 and 2012. Leukocyte differential counts (neutrophil, lymphocyte, monocyte, eosinophil, basophil, and platelet), SIR markers including neutrophil to lymphocyte ratio (NLR), monocyte to lymphocyte ratio (MLR), and platelet to lymphocyte ratio (PLR), and CA-125 levels were estimated to select potential markers for clinical outcomes.
Results
Among potential markers (neutrophil, monocyte, platelet, NLR, MLR, PLR, and CA-125 levels) selected by stepwise comparison, CA-125 levels were best at predicting advanced stage disease, suboptimal debulking and platinum-resistance (cut-off values, ≥ 46.5, ≥ 11.45, and ≥ 66.4 U/mL; accuracies, 69.4%, 78.7%, and 68.5%) while PLR ≥ 205.4 predicted noncomplete response (CR; accuracy, 71.6%) most accurately. Moreover, PLR < 205.4 was an independent factor for the reduced risk of non-CR (adjusted odds ratio, 0.17; 95% confidence interval [CI], 0.04 to 0.69), and NLR < 2.8 was a favorable factor for improved progression-free survival (PFS; adjusted hazard ratio, 0.49; 95% CI, 0.25 to 0.99) despite lack of a marker for overall survival among the potential markers.
Conclusion
CA-125 levels may be the most useful marker for predicting advanced-stage disease. Suboptimal debulking and platinum-resistance, and PLR and NLR may be most effective to predict non-CR and PFS in patients with OCCC.

Citations

Citations to this article as recorded by  
  • Correlation between pre-operative platelets count and serum cancer antigen-125 level in epithelial ovarian carcer
    Justina Omoikhefe Alegbeleye, Celestine Osita John
    Indian Journal of Obstetrics and Gynecology Research.2024; 11(1): 17.     CrossRef
  • Trends in survival of ovarian clear cell carcinoma patients from 2000 to 2015
    Bing-Qian Tian, Shu-Wen Wang, Jing-Ying Xu, San-Gang Wu, Juan Zhou
    Frontiers in Oncology.2024;[Epub]     CrossRef
  • Prognostic value of systemic inflammation response indexes obtained from the complete blood count in patients treated for advanced ovarian carcinoma in front line
    Jaime Espinós, José Manuel Aramendía, Antonio González-Martín, Marta Santisteban, Luisa Sánchez, Ángel Vizcay, José Ángel Mínguez, Juan Luis Alcázar
    Clinical and Translational Oncology.2024; 26(12): 3211.     CrossRef
  • The prognostic and clinical value of neutrophil-to-lymphocyte ratio (NLR) in ovarian cancer: A systematic review and meta-analysis
    Zihan Zhang, Jinghe Lang
    Journal of Medical Biochemistry.2024; 43(4): 323.     CrossRef
  • Combined use of CA125, neutrophil/lymphocyte ratio and platelet/lymphocyte ratio for the diagnosis of borderline and malignant epithelial ovarian tumors
    Ke Huang, Shengjie Xu, Jiatong Wang, Lili Ge, Juan Xu, Xuemei Jia
    Journal of Ovarian Research.2023;[Epub]     CrossRef
  • Independent predictive value of blood inflammatory composite markers in ovarian cancer: recent clinical evidence and perspective focusing on NLR and PLR
    Chuan-long Zhang, Xiao-chen Jiang, Yi Li, Xue Pan, Meng-qi Gao, Yan Chen, Bo Pang
    Journal of Ovarian Research.2023;[Epub]     CrossRef
  • Trends in Systemic Inflammatory Reaction (SIR) during Paclitaxel and Carboplatin Chemotherapy in Women Suffering from Epithelial Ovarian Cancer
    Michal Mleko, Elzbieta Pluta, Kazimierz Pitynski, Maciej Bodzek, Andrzej Kałamacki, Dorota Kiprian, Tomasz Banas
    Cancers.2023; 15(14): 3607.     CrossRef
  • Research Progress of the Relationship between Peripheral Blood Indexes and the Diagnosis, Treatment and Prognosis of Ovarian Cancer
    洁 严
    Advances in Clinical Medicine.2023; 13(11): 17362.     CrossRef
  • Diagnostic significance of neutrophil to lymphocyte ratio in endometriosis: a systematic review and meta-analysis
    Fatemeh Tabatabaei, Hossein Tahernia, Arshin Ghaedi, Aida Bazrgar, Shokoufeh Khanzadeh
    BMC Women's Health.2023;[Epub]     CrossRef
  • Comparison of Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio levels in ovarian cyst among epithelial ovarian cancer patients at RSUP H. Adam Malik Medan, Indonesia
    Mega Sari Dewi, Roy Yustin Simanjuntak, Letta Sari Lintang, Muhammad Fahdhy, Deri Edianto, Makmur Sitepu
    Majalah Obstetri & Ginekologi.2023; 31(3): 117.     CrossRef
  • The role of IL-6/JAK2/STAT3 signaling pathway in cancers
    Bei Huang, Xiaoling Lang, Xihong Li
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Evaluation of CA-125 Biomarker in Acute Appendicitis Patients: Correlation with Clinical Symptoms and Lab Results
    Mojtaba Ahmadinejad, Seyed A. Hashemi, Alireza Shirzadi, Ali Soltanian, Jafar Ashrafi, Kourosh Kabir, Mahla Alizadeh
    The Open Public Health Journal.2021; 14(1): 162.     CrossRef
  • The Use of Platelet/Lymphocyte Ratio and Cancer Antigen 125 Combined with Magnetic Resonance Diffusion-Weighted Imaging in Diagnosis of Recurrent Ovarian Cancer and Neuropathic Pain
    Na Wang, Cuiping Li, Yujie Yang, Yu Guan, Fengjiao Wang, Yan Wang, Wei Zhao
    World Neurosurgery.2021; 149: 502.     CrossRef
  • Role of Systemic Inflammatory Reaction in Female Genital Organ Malignancies – State of the Art
    Michal Mleko, Kazimierz Pitynski, Elzbieta Pluta, Aleksandra Czerw, Katarzyna Sygit, Beata Karakiewicz, Tomasz Banas
    Cancer Management and Research.2021; Volume 13: 5491.     CrossRef
  • The diagnostic value of the combination of hemoglobin, CA199, CA125, and HE4 in endometriosis
    Ting Chen, Jia‐Ling Wei, Ting Leng, Fei Gao, Shun‐yu Hou
    Journal of Clinical Laboratory Analysis.2021;[Epub]     CrossRef
  • Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer
    Carolina Maria Sassu, Innocenza Palaia, Serena Maria Boccia, Giuseppe Caruso, Giorgia Perniola, Federica Tomao, Violante Di Donato, Angela Musella, Ludovico Muzii
    International Journal of Molecular Sciences.2021; 22(24): 13650.     CrossRef
  • Prognostic significance of preoperative circulating FAR and FCI scores in patients with ovarian cancer
    Huige Wang, Yanjun Shen, Xiaoyan Ding, Yongfen Ding, Ling Cheng, Juan Lai
    Clinica Chimica Acta.2020; 509: 252.     CrossRef
  • Serum D-dimer, albumin and systemic inflammatory response markers in ovarian clear cell carcinoma and their prognostic implications
    Wei Chen, Siyuan Zhong, Boer Shan, Shuling Zhou, Xiaohua Wu, Huijuan Yang, Shuang Ye
    Journal of Ovarian Research.2020;[Epub]     CrossRef
  • Preoperative neutrophil-to-lymphocyte ratio predicts 30 day postoperative morbidity and survival after primary surgery for ovarian cancer
    Julie My Van Nguyen, Sarah Elizabeth Ferguson, Marcus Q Bernardini, Taymaa May, Stephane Laframboise, Liat Hogen, Geneviève Bouchard-Fortier
    International Journal of Gynecological Cancer.2020; 30(9): 1378.     CrossRef
  • Sarcopenia: Clinical implications in ovarian cancer, diagnosis, etiology, and management
    Aeran Seol, Se Ik Kim, Yong Sang Song
    Sports Medicine and Health Science.2020; 2(4): 202.     CrossRef
  • Associations between Blood Cell Profiles and Primary Open-Angle Glaucoma: A Retrospective Case-Control Study
    Binghua Tang, Shengjie Li, Jianping Han, Wenjun Cao, Xinghuai Sun
    Ophthalmic Research.2020; 63(4): 413.     CrossRef
  • Prognostic value of neutrophil-to-lymphocyte ratio in early-stage ovarian clear-cell carcinoma
    Kosuke Yoshida, Nobuhisa Yoshikawa, Akira Shirakawa, Kaoru Niimi, Shiro Suzuki, Hiroaki Kajiyama, Fumitaka Kikkawa
    Journal of Gynecologic Oncology.2019;[Epub]     CrossRef
  • Combined score of pretreatment platelet count and CA125 level (PLT-CA125) stratified prognosis in patients with FIGO stage IV epithelial ovarian cancer
    Jie-Ping Chen, Qi-Dan Huang, Ting Wan, Hua Tu, Hai-Feng Gu, Jun-Ya Cao, Ji-Hong Liu
    Journal of Ovarian Research.2019;[Epub]     CrossRef
  • Pretreatment platelet‐to‐lymphocyte ratio is associated with the response to first‐line chemotherapy and survival in patients with metastatic gastric cancer
    Jin Wang, Jinglei Qu, Zhi Li, Xiaofang Che, Jing Liu, Yuee Teng, Bo Jin, Mingfang Zhao, Yunpeng Liu, Xiujuan Qu
    Journal of Clinical Laboratory Analysis.2018;[Epub]     CrossRef
  • Comparison of clinical utility between neutrophil count and neutrophil–lymphocyte ratio in patients with ovarian cancer: a single institutional experience and a literature review
    Naoko Komura, Seiji Mabuchi, Eriko Yokoi, Katsumi Kozasa, Hiromasa Kuroda, Tomoyuki Sasano, Yuri Matsumoto, Tadashi Kimura
    International Journal of Clinical Oncology.2018; 23(1): 104.     CrossRef
  • Prognostic roles of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in ovarian cancer: a meta-analysis of retrospective studies
    Zhe Zhao, Xinrui Zhao, Jingjing Lu, Jing Xue, Peishu Liu, Hongluan Mao
    Archives of Gynecology and Obstetrics.2018; 297(4): 849.     CrossRef
  • The Predictive Value of Inflammation-Related Peripheral Blood Measurements in Cancer Staging and Prognosis
    Joanna L. Sylman, Annachiara Mitrugno, Michelle Atallah, Garth W. Tormoen, Joseph J. Shatzel, Samuel Tassi Yunga, Todd H. Wagner, John T. Leppert, Parag Mallick, Owen J. T. McCarty
    Frontiers in Oncology.2018;[Epub]     CrossRef
  • Analysis of preoperative blood platelet parameters in terms of diversity of epithelial ovarian cancer
    Katarzyna Bednarska, Ewa Król, Ewa Głowacka, Hanna Romanowicz, Krzysztof Szyłło, Magdalena Klink, Zofia Sułowska, Marek Nowak
    Medicine.2018; 97(12): e0180.     CrossRef
  • Inflammatory Indexes as Prognostic and Predictive Factors in Ovarian Cancer Treated with Chemotherapy Alone or Together with Bevacizumab. A Multicenter, Retrospective Analysis by the MITO Group (MITO 24)
    Alberto Farolfi, Micaela Petrone, Emanuela Scarpi, Valentina Gallà, Filippo Greco, Claudia Casanova, Lucia Longo, Gennaro Cormio, Michele Orditura, Alessandra Bologna, Laura Zavallone, Jole Ventriglia, Elisena Franzese, Vera Loizzi, Donatella Giardina, Ev
    Targeted Oncology.2018; 13(4): 469.     CrossRef
  • Prognostic Value of Serum CA19-9 and Perioperative CA-125 Levels in Ovarian Clear Cell Carcinoma
    Jun Zhu, Long Jiang, Hao Wen, Rui Bi, Xiaohua Wu, Xingzhu Ju
    International Journal of Gynecological Cancer.2018; 28(6): 1108.     CrossRef
  • Prognostic Role of Neutrophil to Lymphocyte Ratio in Ovarian Cancer: A Meta-Analysis
    Gaowen Chen, Lin Zhu, Yulu Yang, Yusheng Long, Xiangyuan Li, Yifeng Wang
    Technology in Cancer Research & Treatment.2018;[Epub]     CrossRef
  • Preoperative multiplication of neutrophil and monocyte counts as a prognostic factor in epithelial ovarian cancer
    E Sun Paik, Minhee Shim, Hyun Jin Choi, Yoo-Young Lee, Tae-Joong Kim, Chel Hun Choi, Jeong-Won Lee, Byoung-Gie Kim, Duk-Soo Bae
    Cancer Biomarkers.2017; 17(4): 419.     CrossRef
  • Is the neutrophil-to-lymphocyte ratio prognostic of survival outcomes in gynecologic cancers? A systematic review and meta-analysis
    Josee-Lyne Ethier, Danielle N Desautels, Arnoud J Templeton, Amit Oza, Eitan Amir, Stephanie Lheureux
    Gynecologic Oncology.2017; 145(3): 584.     CrossRef
  • The diagnostic efficacy of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in ovarian cancer
    Anastasia Prodromidou, Panagiotis Andreakos, Charalampos Kazakos, Dimitrios Eftimios Vlachos, Despina Perrea, Vasilios Pergialiotis
    Inflammation Research.2017; 66(6): 467.     CrossRef
  • The value of the combination of hemoglobin, albumin, lymphocyte and platelet in predicting platinum-based chemoradiotherapy response in male patients with esophageal squamous cell carcinoma
    Lihong Cong, Likuan Hu
    International Immunopharmacology.2017; 46: 75.     CrossRef
  • Elevated plasma fibrinogen levels and prognosis of epithelial ovarian cancer: a cohort study and meta-analysis
    Yanlin Luo, Hee Seung Kim, Miseon Kim, Maria Lee, Yong Sang Song
    Journal of Gynecologic Oncology.2017;[Epub]     CrossRef
  • Adipose Stromal Cells from Visceral and Subcutaneous Fat Facilitate Migration of Ovarian Cancer Cells via IL-6/JAK2/STAT3 Pathway
    Boyun Kim, Hee Seung Kim, Soochi Kim, Guy Haegeman, Benjamin K. Tsang, Danny N. Dhanasekaran, Yong Sang Song
    Cancer Research and Treatment.2017; 49(2): 338.     CrossRef
  • Prognostic significance and predictors of the system inflammation score in ovarian clear cell carcinoma
    Hongwei Zhang, Jiaqi Lu, Yingying Lu, Jiayi Zhou, Zehua Wang, Haiou Liu, Congjian Xu, Renato Franco
    PLOS ONE.2017; 12(5): e0177520.     CrossRef
  • Neutrophil-to-Lymphocyte Ratio Is a Potential Prognostic Biomarker in Patients with Ovarian Cancer: A Meta-Analysis
    Shubo Chen, Liu Zhang, Guangyue Yan, Sijin Cheng, Abdel Hamid Fathy, Nana Yan, Yongzhao Zhao
    BioMed Research International.2017; 2017: 1.     CrossRef
  • Prognostic significance of neutrophil to lymphocyte ratio in ovarian cancer: evidence from 4,910 patients
    Quan Zhou, Li Hong, Man-Zhen Zuo, Ze He
    Oncotarget.2017; 8(40): 68938.     CrossRef
  • Predictive value of systematic inflammatory response biomarkers (NLR, LMR, PLR) in patients with ovarian cancer.
    Urszula Rychlik, Ewa Wójcik, Jadwiga Tarapacz, Katarzyna Brandys, Zofia Stasik, Beata Kala, Jan K. Kulpa, Wiktor Szatkowski, Paweł Blecharz, Jerzy Jakubowicz
    Diagnostyka Laboratoryjna.2017; 53(3): 139.     CrossRef
  • Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy
    Yi Miao, Qin Yan, Shuangdi Li, Bilan Li, Youji Feng
    Cancer Biomarkers.2016; 17(1): 33.     CrossRef
  • Serum carbohydrate antigen 125 concentration as a superior predictor for serosal effusion at diagnosis and a prognostic factor in diffuse large B-cell lymphoma
    Jia-Zhu Wu, Tian Tian, Ying Huang, Jin-Hua Liang, Yi Miao, Li Wang, Ji Xu, Xiao-Yan Qu, Lei Fan, Jian-Yong Li, Wei Xu
    Cancer Biomarkers.2016; 17(2): 205.     CrossRef
  • The prognostic value of pretreatment CA-125 levels and CA-125 normalization in ovarian clear cell carcinoma: a two-academic-institute study
    Huimin Bai, Guisha Sha, Meizhu Xiao, Huiqiao Gao, Dongyan Cao, Jiaxin Yang, Jie Chen, Yue Wang, Zhenyu Zhang, Keng Shen
    Oncotarget.2016; 7(13): 15566.     CrossRef
  • Infrequent Expression of the Cancer-Testis Antigen, PASD1, in Ovarian Cancer
    Ghazala Khan, Suzanne E. Brooks, Ken I. Mills, Barbara-Ann Guinn
    Biomarkers in Cancer.2015; 7: BIC.S28378.     CrossRef
  • 17,214 View
  • 166 Download
  • 50 Web of Science
  • 45 Crossref
Close layer
Clinical Implications of VEGF, TGF-beta1, and IL-1beta in Patients with Advanced Non-small Cell Lung Cancer
Ji-Won Kim, Youngil Koh, Dong-Wan Kim, Yong-Oon Ahn, Tae Min Kim, Sae-Won Han, Do-Youn Oh, Se-Hoon Lee, Seock-Ah Im, Tae-You Kim, Dae Seog Heo, Yung-Jue Bang
Cancer Res Treat. 2013;45(4):325-333.   Published online December 31, 2013
DOI: https://doi.org/10.4143/crt.2013.45.4.325
AbstractAbstract PDFPubReaderePub
PURPOSE
Vascular endothelial growth factor (VEGF)-A, VEGF165b, interleukin (IL)-1beta, and transforming growth factor (TGF)-beta1 are known to influence tumor angiogenesis. Clinical implications of these cytokines need to be elucidated.
MATERIALS AND METHODS
Using clinical data and baseline serum samples of 140 consecutive patients with advanced non-small cell lung cancer who received platinum-based combination chemotherapy, we investigated the association among serum cytokine levels, treatment outcomes, as well as leukocyte and platelet counts.
RESULTS
The median age of patients was 64 years (range, 26 to 86 years). The male to female ratio was 104:36. High TGF-beta1 and IL-1beta levels were associated with shorter progression-free survival, and high VEGF-A and IL-1beta levels were associated with shorter overall survival in the univariate analysis. VEGF165b was not related to the treatment outcomes. Leukocytosis and thrombocytosis were associated with shorter overall survival. The multivariate analysis demonstrated that VEGF-A, IL-1beta, and leukocytosis were significant prognostic factors (p=0.0497, p=0.047, and p<0.001, respectively). Leukocytosis was not associated with recent pneumonia (p=0.937) and correlated with VEGF-A (p<0.001) and TGF-beta1 (p=0.020) levels.
CONCLUSION
Serum VEGF-A, TGF-1beta, and IL-1beta levels, in addition to leukocyte and platelet counts, are shown to be associated with clinical outcomes. Leukocyte and platelet counts are correlated with serum VEGF-A and TGF-beta1 levels.

Citations

Citations to this article as recorded by  
  • Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non–Small-Cell Lung Cancer: Results From the CANOPY-1 Trial
    Daniel S.W. Tan, Enriqueta Felip, Gilberto de Castro, Benjamin J. Solomon, Alastair Greystoke, Byoung Chul Cho, Manuel Cobo, Tae Min Kim, Sandip Ganguly, Enric Carcereny, Luis Paz-Ares, Jaafar Bennouna, Marina Chiara Garassino, Michael Schenker, Sang-We K
    Journal of Clinical Oncology.2024; 42(2): 192.     CrossRef
  • Canakinumab in combination with docetaxel compared with docetaxel alone for the treatment of advanced non-small cell lung cancer following platinum-based doublet chemotherapy and immunotherapy (CANOPY-2): A multicenter, randomized, double-blind, phase 3 t
    Luis Paz-Ares, Yasushi Goto, Darren Wan-Teck Lim, Balazs Halmos, Byoung Chul Cho, Manuel Cobo, José Luis González Larriba, Caicun Zhou, Ingel Demedts, Akin Atmaca, Sofia Baka, Bijoyesh Mookerjee, Socorro Portella, Zewen Zhu, Jincheng Wu, David Demanse, Bh
    Lung Cancer.2024; 189: 107451.     CrossRef
  • Targeting Notch-Driven Cytokine Secretion: Novel Therapies for Triple Negative Breast Cancer
    Wanda Marini, Brooke E. Wilson, Michael Reedijk
    DNA and Cell Biology.2023; 42(2): 73.     CrossRef
  • IL-1β is involved in docetaxel chemoresistance by regulating the formation of polyploid giant cancer cells in non-small cell lung cancer
    Song Zhao, Sining Xing, Lili Wang, Mingyue Ouyang, Shuo Liu, Lingyan Sun, Huiying Yu
    Scientific Reports.2023;[Epub]     CrossRef
  • Prognostic Implications of Pyroptosis-Related Gene Signatures in Lung Squamous Cell Carcinoma
    Tingting Li, Huanqing Liu, Chunsheng Dong, Jun Lyu
    Frontiers in Pharmacology.2022;[Epub]     CrossRef
  • Recruitment and activation of type 3 innate lymphoid cells promote antitumor immune responses
    Mélanie Bruchard, Mannon Geindreau, Anaïs Perrichet, Caroline Truntzer, Elise Ballot, Romain Boidot, Cindy Racoeur, Emilie Barsac, Fanny Chalmin, Christophe Hibos, Thomas Baranek, Christophe Paget, Bernhard Ryffel, Cédric Rébé, Catherine Paul, Frédérique
    Nature Immunology.2022; 23(2): 262.     CrossRef
  • Targeting interleukin-1β and inflammation in lung cancer
    Jun Zhang, Nirmal Veeramachaneni
    Biomarker Research.2022;[Epub]     CrossRef
  • Immunohistochemical Detection of Pro-Inflammatory and Anti-Inflammatory Interleukins in the Lungs of Sheep with Jaagsiekte
    Emin KARAKURT, Enver BEYTUT, Serpil DAĞ, Hilmi NUHOĞLU, Ayfer YILDIZ, Emre KURTBAŞ
    Turkish Journal of Veterinary Research.2022; 6(1): 9.     CrossRef
  • Implications of Hyperoxia over the Tumor Microenvironment: An Overview Highlighting the Importance of the Immune System
    Ana Belén Herrera-Campos, Esteban Zamudio-Martinez, Daniel Delgado-Bellido, Mónica Fernández-Cortés, Luis M. Montuenga, F. Javier Oliver, Angel Garcia-Diaz
    Cancers.2022; 14(11): 2740.     CrossRef
  • Repositioning canakinumab for non-small cell lung cancer—important lessons for drug repurposing in oncology
    Mark P. Lythgoe, Vinay Prasad
    British Journal of Cancer.2022; 127(5): 785.     CrossRef
  • Promotion of angiogenesis in vitro by Astragalus polysaccharide via activation of TLR4 signaling pathway
    Huiqing Qiu, Liyan Zhang, Xinqi He, Yusen Wei, Miaoran Wang, Bin Ma, Dailun Hu, Zhongli Shi
    Journal of Food Biochemistry.2022;[Epub]     CrossRef
  • B Cell Receptor Signaling Pathway Mutation as Prognosis Predictor of Immune Checkpoint Inhibitors in Lung Adenocarcinoma by Bioinformatic Analysis
    Anqi Lin, Jianbo Fang, Quan Cheng, Zaoqu Liu, Peng Luo, Jian Zhang
    Journal of Inflammation Research.2022; Volume 15: 5541.     CrossRef
  • Biological Rationale for Peripheral Blood Cell–Derived Inflammatory Indices and Related Prognostic Scores in Patients with Advanced Non-Small-Cell Lung Cancer
    Giuseppe Luigi Banna, Alex Friedlaender, Marco Tagliamento, Veronica Mollica, Alessio Cortellini, Sara Elena Rebuzzi, Arsela Prelaj, Abdul Rafeh Naqash, Edouard Auclin, Lucia Garetto, Laura Mezquita, Alfredo Addeo
    Current Oncology Reports.2022; 24(12): 1851.     CrossRef
  • IL-1β enhances cell viability and decreases 5-FU sensitivity in novel colon cancer cell lines derived from African American patients
    Marzia Spagnardi, Jenny Paredes, Jovanny Zabaleta, Jone Garai, Tiana Reyes, Laura A. Martello, Jennie L. Williams
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Immune Resistance in Lung Adenocarcinoma
    Magda Spella, Georgios T. Stathopoulos
    Cancers.2021; 13(3): 384.     CrossRef
  • The Role of Tumor Inflammatory Microenvironment in Lung Cancer
    Zhaofeng Tan, Haibin Xue, Yuli Sun, Chuanlong Zhang, Yonglei Song, Yuanfu Qi
    Frontiers in Pharmacology.2021;[Epub]     CrossRef
  • Interleukin-1β and Cancer
    Cédric Rébé, François Ghiringhelli
    Cancers.2020; 12(7): 1791.     CrossRef
  • Immune Cells Combined With NLRP3 Inflammasome Inhibitor Exert Better Antitumor Effect on Pancreatic Ductal Adenocarcinoma
    Hailiang Liu, Yong Xu, Kai Liang, Rong Liu
    Frontiers in Oncology.2020;[Epub]     CrossRef
  • Identification of a novel subpopulation of Caspase-4 positive non-small cell lung Cancer patients
    Michela Terlizzi, Chiara Colarusso, Ilaria De Rosa, Pasquale Somma, Carlo Curcio, Rita P. Aquino, Luigi Panico, Rosario Salvi, Federica Zito Marino, Gerardo Botti, Aldo Pinto, Rosalinda Sorrentino
    Journal of Experimental & Clinical Cancer Research.2020;[Epub]     CrossRef
  • A review of canakinumab and its therapeutic potential for non-small cell lung cancer
    Kara M. Schenk, Joshua E. Reuss, Karin Choquette, Alexander I. Spira
    Anti-Cancer Drugs.2019; 30(9): 879.     CrossRef
  • Listeria monocytogenes Cancer Vaccines: Bridging Innate and Adaptive Immunity
    Zachary T. Morrow, Zachary M. Powers, John-Demian Sauer
    Current Clinical Microbiology Reports.2019; 6(4): 213.     CrossRef
  • Cell Death, Inflammation, Tumor Burden, and Proliferation Blood Biomarkers Predict Lung Cancer Radiotherapy Response and Correlate With Tumor Volume and Proliferation Imaging
    Ahmed Salem, Hitesh Mistry, Alison Backen, Clare Hodgson, Pek Koh, Emma Dean, Lynsey Priest, Kate Haslett, Ioannis Trigonis, Alan Jackson, Marie-Claude Asselin, Caroline Dive, Andrew Renehan, Corinne Faivre-Finn, Fiona Blackhall
    Clinical Lung Cancer.2018; 19(3): 239.     CrossRef
  • Elucidating the Role of CD84 and AHR in Modulation of LPS-Induced Cytokines Production by Cruciferous Vegetable-Derived Compounds Indole-3-Carbinol and 3,3′-Diindolylmethane
    Thomas Wang, Quynhchi Pham, Young Kim
    International Journal of Molecular Sciences.2018; 19(2): 339.     CrossRef
  • IL‐1β promotes the nuclear translocaiton of S100A4 protein in gastric cancer cells MGC803 and the cell's stem‐like properties through PI3K pathway
    Aiwen Yu, Yu Wang, Yue Bian, Lisha Chen, Junfu Guo, Wei Shen, Danqi Chen, Shanshan Liu, Xiuju Sun
    Journal of Cellular Biochemistry.2018; 119(10): 8163.     CrossRef
  • SNAI2 and TWIST1 in lymph node progression in early stages of NSCLC patients
    Camille Emprou, Pauline Le Van Quyen, Jérémie Jégu, Nathalie Prim, Noëlle Weingertner, Eric Guérin, Erwan Pencreach, Michèle Legrain, Anne‐Claire Voegeli, Charlotte Leduc, Bertrand Mennecier, Pierre‐Emmanuel Falcoz, Anne Olland, Nicolas Santelmo, Elisabet
    Cancer Medicine.2018; 7(7): 3278.     CrossRef
  • RNA-Sequencing data supports the existence of novel VEGFA splicing events but not of VEGFAxxxb isoforms
    Stephen Bridgett, Margaret Dellett, David A. Simpson
    Scientific Reports.2017;[Epub]     CrossRef
  • Cordycepin inhibits LPS-induced inflammatory responses by modulating NOD-Like Receptor Protein 3 inflammasome activation
    Jing Yang, Yun-zhou Li, Phillip B. Hylemon, Lu-yong Zhang, Hui-ping Zhou
    Biomedicine & Pharmacotherapy.2017; 95: 1777.     CrossRef
  • Syndrome of Inappropriate Antidiuretic Hormone Secretion: A Poor Prognosis in Small-cell Lung Cancer
    Xu Wang, Min Liu, Lei Zhang, Kewei Ma
    Archives of Medical Research.2016; 47(1): 19.     CrossRef
  • Prediction of survival and tumor recurrence in patients undergoing surgery for pancreatic neuroendocrine neoplasms
    Alexander Kaltenborn, Svenja Matzke, Moritz Kleine, Till Krech, Wolf Ramackers, Florian W. R. Vondran, Jürgen Klempnauer, Hüseyin Bektas, Harald Schrem
    Journal of Surgical Oncology.2016; 113(2): 194.     CrossRef
  • Association of CT perfusion imaging with plasma levels of TGF-β1 and VEGF in patients with NSCLC
    Da-Wei Li, Bao-Zhong Wu, Yu-Sen Shi, Zhi-Qun Li, Xu-Dong Liu, Xiao-Hua Li
    Asian Pacific Journal of Tropical Medicine.2016; 9(2): 177.     CrossRef
  • Promotion of a cancer-like phenotype, through chronic exposure to inflammatory cytokines and hypoxia in a bronchial epithelial cell line model
    Anne-Marie Baird, Steven G. Gray, Derek J. Richard, Kenneth J. O’Byrne
    Scientific Reports.2016;[Epub]     CrossRef
  • Dysregulation of TGFβ1 Activity in Cancer and Its Influence on the Quality of Anti-Tumor Immunity
    Kristian Hargadon
    Journal of Clinical Medicine.2016; 5(9): 76.     CrossRef
  • Associations of Circulating Cytokines and Chemokines With Cancer Mortality in Men With Rheumatoid Arthritis
    Bryant R. England, Jeremy Sokolove, William H. Robinson, Geoffrey M. Thiele, Apar K. Ganti, Harlan Sayles, Kaleb Michaud, Liron Caplan, Lisa A. Davis, Grant W. Cannon, Brian Sauer, Namrata Singh, E. Blair Solow, Andreas M. Reimold, Gail S. Kerr, Pascale S
    Arthritis & Rheumatology.2016; 68(10): 2394.     CrossRef
  • The inflammasome: an emerging therapeutic oncotarget for cancer prevention
    Wang Zhiyu, Neng Wang, Qi Wang, Cheng Peng, Jin Zhang, Pengxi Liu, Aihua Ou, Shaowen Zhong, Mario D. Cordero, Yi Lin
    Oncotarget.2016; 7(31): 50766.     CrossRef
  • Elevated chronic inflammatory factors and myeloid‐derived suppressor cells indicate poor prognosis in advanced melanoma patients
    Huanhuan Jiang, Christoffer Gebhardt, Ludmila Umansky, Philipp Beckhove, Torsten J. Schulze, Jochen Utikal, Viktor Umansky
    International Journal of Cancer.2015; 136(10): 2352.     CrossRef
  • The Clinical Research of Serum VEGF, TGF-β1, and Endostatin in Non-small Cell Lung Cancer
    Shu-Guang Liu, Shuang-Hu Yuan, Hui-Yong Wu, Jie Liu, Cheng-Suo Huang
    Cell Biochemistry and Biophysics.2015; 72(1): 165.     CrossRef
  • Platelet VEGF and serum TGF-β1 levels predict chemotherapy response in non-small cell lung cancer patients
    Bao-Hong Fu, Zhan-Zhao Fu, Wei Meng, Tao Gu, Xiao-Dong Sun, Zhi Zhang
    Tumor Biology.2015; 36(8): 6477.     CrossRef
  • Pulmonary Large-Cell Neuroendocrine Carcinoma: From Epidemiology to Therapy
    Morena Fasano, Carminia Maria Della Corte, Federica Papaccio, Fortunato Ciardiello, Floriana Morgillo
    Journal of Thoracic Oncology.2015; 10(8): 1133.     CrossRef
  • The angiogenic responses induced by release of angiogenic proteins from tumor cell‐activated platelets are regulated by distinct molecular pathways
    Hongyan Wu, Fangtian Fan, Zhaoguo Liu, Feng Zhang, Yuping Liu, Zhonghong Wei, Cunsi Shen, Yuzhu Cao, Aiyun Wang, Yin Lu
    IUBMB Life.2015; 67(8): 626.     CrossRef
  • Serum Calprotectin, CD26 and EGF to Establish a Panel for the Diagnosis of Lung Cancer
    Sonia Blanco-Prieto, Lorena Vázquez-Iglesias, Mar Rodríguez-Girondo, Leticia Barcia-Castro, Alberto Fernández-Villar, María Isabel Botana-Rial, Francisco Javier Rodríguez-Berrocal, María Páez de la Cadena, Rossella Rota
    PLOS ONE.2015; 10(5): e0127318.     CrossRef
  • 14,199 View
  • 104 Download
  • 47 Web of Science
  • 40 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP